96 weeks treatment of tenofovir alafenamide vs. tenofovir disoproxil fumarate for hepatitis B virus infection-Reference-Cited by-同舟云学术

96 weeks treatment of tenofovir alafenamide vs. tenofovir disoproxil fumarate for hepatitis B virus infection

Published:2018-04 Issue:4 Volume:68 Page:672-681
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Agarwal Kosh,Brunetto Maurizia,Seto Wai Kay,Lim Young-Suk,Fung Scott,Marcellin Patrick,Ahn Sang Hoon,Izumi Namiki,Chuang Wan–Long,Bae Ho,Sharma Manoj,Janssen Harry L.A.,Pan Calvin Q.,Çelen Mustafa Kemal,Furusyo Norihiro,Shalimar Dr.,Yoon Ki Tae,Trinh Huy,Flaherty John F.,Gaggar Anuj,Lau Audrey H.,Cathcart Andrea L.,Lin Lanjia,Bhardwaj Neeru,Suri Vithika,Mani Subramanian G.,Gane Edward J.,Buti Maria,Chan Henry L.Y.

Funder

Gilead Sciences

Publisher

Elsevier BV

Subject

Hepatology

Reference34 articles.

1. World Health Organization. Hepatitis B fact sheet. http://www.who.int/mediacentre/factsheets/fs204/en/.

2. Hepatitis B virus infection—natural history and clinical consequences;Ganem;N Engl J Med,2004

3. Chronic hepatitis B virus infection;McMahon;Med Clin North Am,2014

4. Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors;Fattovich;J Hepatol,2008

5. Chronic hepatitis B: virology, natural history, current management and a glimpse at future opportunities;Gish;Antivir Res,2015

Cited by 312 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative efficacy and safety of tenofovir amibufenamide vs tenofovir alafenamide in the initial 48-week treatment of high viral load chronic hepatitis B: A single-centre retrospective study;Antiviral Therapy;2024-09-11

2. Risk factors related to low-level viraemia in chronic hepatitis B patients receiving entecavir treatment;Frontiers in Cellular and Infection Microbiology;2024-08-07

3. Clinical Efficacy and Safety of Long-Term Treatment of Tenofovir Alafenamide vs Tenofovir Disoproxil Fumarate for Chronic Hepatitis B in Vietnam;Clinical and Translational Gastroenterology;2024-07-18

4. Efficacy comparison of high-genetic barrier nucleos(t)ide analogues in treatment-naïve chronic hepatitis B patients: a network meta-analysis;The Korean Journal of Internal Medicine;2024-07-01

5. Metabolic effects and cardiovascular disease risks of antiviral treatments in patients with chronic hepatitis B;Journal of Medical Virology;2024-06-28